|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,431.00 JPY | +3.60% |
|
-0.76% | +11.88% |
| Market Cap | 1,103B 6.79B 5.93B 5.49B 5.03B 9.53B 654B 9.69B 65.43B 25.7B 319B 25.49B 24.93B | P/E 2027 * |
15.5x | P/E 2028 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 903B 5.56B 4.86B 4.5B 4.13B 7.81B 536B 7.94B 53.61B 21.06B 262B 20.88B 20.43B | EV / Sales 2027 * |
1.99x | EV / Sales 2028 * | 1.99x |
| Free-Float |
80.98% | Yield 2027 * |
3.34% | Yield 2028 * | 3.3% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +3.58% | ||
| 1 week | -0.76% | ||
| Current month | +1.78% | ||
| 1 month | +7.59% | ||
| 3 months | -2.47% | ||
| 6 months | +7.52% | ||
| Current year | +11.88% |
| 1 week | 2,344.5 | 2,471.5 | |
| 1 month | 2,208 | 2,507 | |
| Current year | 2,114.5 | 2,674.5 | |
| 1 year | 1,579.5 | 2,674.5 | |
| 3 years | 1,474 | 2,966.5 | |
| 5 years | 1,474 | 3,990 | |
| 10 years | 1,474 | 4,107 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 76 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.60% | -0.76% | +46.42% | -3.55% | 6.92B | ||
| -0.07% | +3.28% | +12.89% | +81.75% | 48.66B | ||
| +1.32% | +0.99% | +69.73% | +115.50% | 35.52B | ||
| -0.59% | -0.16% | -4.12% | +38.67% | 12.07B | ||
| -0.26% | +0.51% | +19.25% | +93.82% | 11.99B | ||
| 0.00% | +2.29% | +34.34% | +129.06% | 9.29B | ||
| +0.50% | +0.50% | +19.50% | +37.94% | 7B | ||
| -0.46% | +2.84% | +2.73% | +225.72% | 6.74B | ||
| +7.04% | +14.92% | -10.65% | +29.12% | 6.36B | ||
| -0.04% | +5.31% | +27.99% | +139.09% | 4.48B | ||
| Average | +1.11% | +2.15% | +21.81% | +88.71% | 14.9B | |
| Weighted average by Cap. | +0.71% | +1.54% | +27.76% | +90.19% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 454B 2.8B 2.44B 2.26B 2.07B 3.93B 269B 3.99B 26.96B 10.59B 132B 10.5B 10.27B | 444B 2.74B 2.39B 2.21B 2.03B 3.84B 264B 3.91B 26.38B 10.36B 129B 10.27B 10.05B |
| Net income | 70.97B 437M 382M 353M 324M 613M 42.1B 624M 4.21B 1.65B 20.56B 1.64B 1.6B | 62.51B 385M 336M 311M 285M 540M 37.08B 550M 3.71B 1.46B 18.11B 1.45B 1.41B |
| Net Debt | -199B -1.23B -1.07B -991M -910M -1.72B -118B -1.75B -11.82B -4.64B -57.7B -4.6B -4.5B | -218B -1.34B -1.17B -1.09B -996M -1.89B -129B -1.92B -12.95B -5.09B -63.21B -5.04B -4.93B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | JP¥2,431.00 | +3.60% | 274,800 |
| 26-07-16 | JP¥2,346.50 | -1.76% | 1,579,900 |
| 26-07-15 | JP¥2,388.50 | -1.81% | 1,516,100 |
| 26-07-14 | JP¥2,432.50 | +1.33% | 1,327,200 |
| 26-07-13 | JP¥2,400.50 | -1.13% | 1,072,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions

















